BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 19234209)

  • 1. Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response.
    Liston A; Kohler RE; Townley S; Haylock-Jacobs S; Comerford I; Caon AC; Webster J; Harrison JM; Swann J; Clark-Lewis I; Korner H; McColl SR
    J Immunol; 2009 Mar; 182(5):3121-30. PubMed ID: 19234209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
    Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.
    Hesske L; Vincenzetti C; Heikenwalder M; Prinz M; Reith W; Fontana A; Suter T
    Brain; 2010 Jun; 133(Pt 6):1637-54. PubMed ID: 20424288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
    van Zwam M; Huizinga R; Heijmans N; van Meurs M; Wierenga-Wolf AF; Melief MJ; Hintzen RQ; 't Hart BA; Amor S; Boven LA; Laman JD
    J Pathol; 2009 Mar; 217(4):543-51. PubMed ID: 19023878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes.
    Zhou Y; Sonobe Y; Akahori T; Jin S; Kawanokuchi J; Noda M; Iwakura Y; Mizuno T; Suzumura A
    J Immunol; 2011 Apr; 186(7):4415-21. PubMed ID: 21346235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis.
    Moriguchi K; Miyamoto K; Tanaka N; Yoshie O; Kusunoki S
    J Neuroimmunol; 2013 Apr; 257(1-2):53-8. PubMed ID: 23477966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system.
    Kohler RE; Caon AC; Willenborg DO; Clark-Lewis I; McColl SR
    J Immunol; 2003 Jun; 170(12):6298-306. PubMed ID: 12794163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental autoimmune encephalomyelitis develops in CC chemokine receptor 7-deficient mice with altered T-cell responses.
    Pahuja A; Maki RA; Hevezi PA; Chen A; Verge GM; Lechner SM; Roth RB; Zlotnik A; Alleva DG
    Scand J Immunol; 2006 Oct; 64(4):361-9. PubMed ID: 16970675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
    Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis.
    Williams IR
    Ann N Y Acad Sci; 2006 Aug; 1072():52-61. PubMed ID: 17057190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro.
    Ambrosini E; Columba-Cabezas S; Serafini B; Muscella A; Aloisi F
    Glia; 2003 Feb; 41(3):290-300. PubMed ID: 12528183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40L+ CD4+ memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming.
    Martín-Fontecha A; Baumjohann D; Guarda G; Reboldi A; Hons M; Lanzavecchia A; Sallusto F
    J Exp Med; 2008 Oct; 205(11):2561-74. PubMed ID: 18838544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis.
    Serafini B; Columba-Cabezas S; Di Rosa F; Aloisi F
    Am J Pathol; 2000 Dec; 157(6):1991-2002. PubMed ID: 11106572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
    Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF
    Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
    Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
    J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis.
    Wang J; Lu ZH; Gabius HJ; Rohowsky-Kochan C; Ledeen RW; Wu G
    J Immunol; 2009 Apr; 182(7):4036-45. PubMed ID: 19299701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo.
    Le Borgne M; Etchart N; Goubier A; Lira SA; Sirard JC; van Rooijen N; Caux C; Aït-Yahia S; Vicari A; Kaiserlian D; Dubois B
    Immunity; 2006 Feb; 24(2):191-201. PubMed ID: 16473831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
    Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
    J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice deficient in PKC theta demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseases.
    Anderson K; Fitzgerald M; Dupont M; Wang T; Paz N; Dorsch M; Healy A; Xu Y; Ocain T; Schopf L; Jaffee B; Picarella D
    Autoimmunity; 2006 Sep; 39(6):469-78. PubMed ID: 17060026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic and protective functions of TNF in neuroinflammation are defined by its expression in T lymphocytes and myeloid cells.
    Kruglov AA; Lampropoulou V; Fillatreau S; Nedospasov SA
    J Immunol; 2011 Dec; 187(11):5660-70. PubMed ID: 22058414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.